In the United States.

In the United States, this drug is currently approved by the Food and Drug Administration for reducing signs and symptoms of osteoarthritis. – ‘Evidence of the large TARGET study has shown that Prexige is associated with significantly lower increases in blood pressure than commonly used NSAIDs,’said James Shannon, Global Head of Development at Novartis Pharma AG. The study, patientsch underscores the importance of osteoarthritis patients a treatment option , as have Prexige. ‘.

‘NSAIDs, including some COX-2s were associated with elevated blood pressure, this effect may be this effect may be partially responsible brought to the increased risk of cardiovascular diseases with this class of drugs in combination, ‘said Tom MacDonald, Professor of Clinical Pharmacology, said at the Hypertension Research Centre at Ninewells Hospital & Medical School, Dundee, Scotland. ‘These data indicate that can lumiracoxib have less impact on blood pressure than the most commonly used NSAID ibuprofen. ‘.Contacts: Siobhan Gallagher 617-636-6586 Tufts UniversityWhen staying at listen to view more over one of the trials or talk one interested member of Faculty of Friedman School of Nutrition Science and Policy and others Tufts health sciences researcher, please Siobhan Gallagher by e-mail of or by phone at 617-636-6586.

Other Posts From "oncology":

Related Posts